The effectiveness of combination therapy with interferon and nucleoside analogs in pediatric patients with chronic hepatitis B: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

The effectiveness of combination therapy with interferon and nucleoside analogs in pediatric patients with chronic hepatitis B: a systematic review and meta-analysis

Published:2022-12-05 Issue:1 Volume:17 Page:52-62
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Li Min,Li Qinghong,Qu Jianhui,Yang Huiyin,Lv Tingting,Kong Yuanyuan^ORCID,Zhang Hongfei

Funder

High-level public health technical talents of the Beijing Municipal Health Commission

Young Scientists Fund

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

https://link.springer.com/content/pdf/10.1007/s12072-022-10415-7.pdf

Reference28 articles.

1. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211–1259.

2. Polaris Observatory Collaborators. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018;3(6):383–403

3. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546–1555

4. Cui F, Shen L, Li L, et al. Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy. China Emerg Infect Dis. 2017;23(5):765–772

5. Sokal EM, Paganelli M, Wirth S, et al. Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines: consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology Hepatology and Nutrition. J Hepatol. 2013;59(4):814–829

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional cure induced by tenofovir alafenamide plus peginterferon-alpha-2b in young children with chronic hepatitis B: a case series study;BMC Infectious Diseases;2024-08-15

2. Expert Consensus on the Prevention and Treatment of Chronic Hepatitis B in Children;Infectious Diseases & Immunity;2024-06-12

3. Functional cure is associated with younger age in children undergoing antiviral treatment for active chronic hepatitis B;Hepatology International;2024-02-20

4. Letter: Baseline age on antiviral treatment may significantly influence the clinical response of children with chronic hepatitis B;Alimentary Pharmacology & Therapeutics;2024-01-10

5. Efficacy and Safety of Antiviral Therapy for Immune-tolerant Hepatitis B Viral Infection in Children: A Systematic Review and Meta-analysis;Pediatric Infectious Disease Journal;2023-07-31